protocolSection identificationModule nctId: NCT06389695, orgStudyIdInfo id: CP-2023-03, secondaryIdInfos id: NYM032D01, type: OTHER, domain: National Medical Products Administration, briefTitle: Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in Patients, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-05, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-04-29, lastUpdatePostDateStruct date: 2024-04-29, sponsorCollaboratorsModule leadSponsor name: Norroy Bioscience Co., LTD, class: INDUSTRY, descriptionModule briefSummary: 68Ga-NYM032 is a PSMA-targeting small-molecular radiotracer for PET/CT imaging of prostate cancer, which is needed for clinical trial to be conducted, conditionsModule conditions: Prostate Cancer, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: DIAGNOSTIC, maskingInfo masking: NONE, enrollmentInfo count: 10, type: ESTIMATED, armsInterventionsModule interventions name: 68Ga-NYM032 injection, outcomesModule primaryOutcomes measure: Incidence of Adverse Events, eligibilityModule sex: MALE, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Affliated Hospital of Jiangnan University, status: RECRUITING, city: Wuxi, state: Jiangsu, zip: 214000, country: China, contacts name: Chunjing Yu, role: CONTACT, phone: 15312238622, email: ycj_wxd1978@163.com, geoPoint lat: 31.56887, lon: 120.28857, hasResults: False